{"gene":"NFIB","run_date":"2026-04-29T11:37:56","timeline":{"discoveries":[{"year":2005,"finding":"Nfib-deficient mice exhibit defects in lung maturation (failure of saccularization, reduced epithelial differentiation markers), callosal agenesis, forebrain defects more severe than Nfia-null, basilar pons formation defects, and hippocampal developmental abnormalities, establishing NFIB as essential for late fetal lung maturation and brain development; heterozygotes also show haploinsufficiency phenotypes.","method":"Knockout mouse model with histological, molecular, and anatomical phenotypic analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple defined cellular phenotypes, replicated by independent lab (PMID:11850179)","pmids":["15632069","11850179"],"is_preprint":false},{"year":2002,"finding":"Nfib null mutants die early postnatally with severe lung hypoplasia; TGF-β1 and Shh are not downregulated in mutant lung epithelium at late morphogenesis stages, suggesting NFIB-dependent repression of these signaling molecules is required for normal lung maturation.","method":"Knockout mouse model, immunostaining, in situ hybridization","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 2 — clean KO with specific molecular pathway implication; independently corroborated","pmids":["11850179"],"is_preprint":false},{"year":1997,"finding":"NFI-B3, a truncated isoform of NFIB generated by alternative RNA processing (retention of first intron + intron-internal polyadenylation), lacks DNA-binding activity alone but forms heterodimers with other NFI-B, -C, and -X isoforms, reducing their DNA-binding and transcriptional activation in a dominant-negative manner.","method":"In vitro transcription assay in NFI-null SL-2 cells, gel shift (EMSA), co-expression of isoforms","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — functional reconstitution in NFI-null cells, EMSA, mechanistic mutagenesis context","pmids":["9099724"],"is_preprint":false},{"year":2009,"finding":"In Nfib-deficient mice, callosal agenesis results from non-cell-autonomous defects: (1) midline radial progenitors fail to differentiate into mature glia (not due to proliferation/apoptosis changes), and (2) cingulate cortex neurons that express Nfib fail to extend neuropilin-1-positive pioneering axons across the midline, with diminished neuropilin-1 expression.","method":"Knockout mouse histology, retrograde tracer labeling, immunohistochemistry, cellular proliferation/apoptosis assays","journal":"Neural development","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing two distinct non-cell-autonomous mechanisms in KO","pmids":["19961580"],"is_preprint":false},{"year":2009,"finding":"In Nfib-null mice, development of the basilar pontine nuclei is delayed (neurons migrate 1–2 days later than controls) and fewer pontine neurons are produced; other mossy fiber nuclei of the caudal medulla also show developmental delay. Nfia and Nfix null mice show no pontine phenotype, indicating Nfib-specific action.","method":"Knockout mouse immunohistochemistry, comparative analysis of Nfia and Nfix null mice","journal":"The Journal of comparative neurology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with specific neuronal phenotype and genetic specificity established by paralog comparison","pmids":["19107796"],"is_preprint":false},{"year":2013,"finding":"Hair-follicle-stem-cell-specific conditional knockout of Nfib in mice uncouples melanocyte stem cell synchrony from the hair cycle: loss of NFIB in hair follicle stem cells promotes premature melanocyte stem cell proliferation and differentiation via ectopic activation of the NFIB target Edn2 (endothelin 2). Endothelin receptor antagonists or KIT-blocking antibodies rescue the premature melanocyte differentiation phenotype.","method":"Conditional KO mouse, ChIP-seq, transcriptional profiling, pharmacological rescue with receptor antagonists/antibodies","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 — conditional KO, ChIP-seq identification of Edn2 as direct target, multiple orthogonal rescue experiments","pmids":["23389444"],"is_preprint":false},{"year":2014,"finding":"NFIB binds the Ezh2 promoter and represses Ezh2 transcription, thereby limiting neural progenitor cell self-renewal during cortical development; Nfib-null mice show increased EZH2 expression and excess proliferating ventricular zone progenitors, with misregulation of downstream EZH2 epigenetic targets.","method":"Knockout mouse, ChIP (NFIB binding to Ezh2 promoter), NFIB overexpression reporter assay, immunohistochemistry","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 — direct promoter binding (ChIP), overexpression repression assay, and KO phenotype with multiple orthogonal methods","pmids":["24553933"],"is_preprint":false},{"year":2016,"finding":"In a mouse SCLC model, Nfib copy-number amplification correlates with widespread opening of distal chromatin regulatory elements genome-wide; Nfib is necessary and sufficient to increase chromatin accessibility at intergenic regions and drives pro-metastatic neuronal gene expression programs, promoting metastatic spread of SCLC.","method":"Genetically engineered mouse model (GEMM), ATAC-seq (chromatin accessibility), NFIB KD/OE in cancer cells, in vivo metastasis assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 — genome-wide chromatin profiling, functional KD/OE with in vivo metastasis readout, multiple orthogonal methods","pmids":["27374332"],"is_preprint":false},{"year":2016,"finding":"NFIB overexpression specifically promotes metastatic spread (not just primary tumor growth) in Rb1/Trp53-deleted mouse SCLC models; high NFIB levels are associated with poorly differentiated, E-cadherin-negative invasive tumor cell populations.","method":"Mouse SCLC model with NFIB overexpression, histological and immunophenotypic analysis","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — in vivo GEMM with defined metastatic phenotype; corroborated by independent SCLC study (PMID:27374332)","pmids":["27373156"],"is_preprint":false},{"year":2016,"finding":"In mouse SCLC models, Nfib overexpression cooperates with Rb1/Trp53 deletion to accelerate SCLC; Nfib suppression in cell lines increases apoptosis and reduces proliferation; Nfib transcriptionally regulates axon guidance, focal adhesion, and extracellular matrix-receptor interaction gene networks; Nfib amplifications are more frequent in liver metastases than primary tumors.","method":"Mouse SCLC model (doxycycline-inducible Nfib overexpression), cell line Nfib knockdown, transcriptional profiling","journal":"Oncotarget","confidence":"High","confidence_rationale":"Tier 2 — in vivo mouse model plus transcriptome analysis, multiple orthogonal approaches","pmids":["27613844"],"is_preprint":false},{"year":2016,"finding":"Drosha directly targets NFIB mRNA to repress its expression in adult hippocampal neural stem cells, independently of Dicer and microRNAs; Drosha deletion activates oligodendrogenesis and reduces neurogenesis, phenotypes that are rescued by NFIB knockdown, establishing a Drosha/NFIB axis that restricts oligodendrocyte fate acquisition.","method":"Conditional Drosha KO in adult dentate gyrus NSCs, NFIB knockdown rescue experiments, lineage tracing","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis by double KO/KD rescue, clean cellular phenotype with defined molecular mechanism","pmids":["27545503"],"is_preprint":false},{"year":2014,"finding":"NFIB (together with STAT5) co-regulates mammary-specific genetic programs: ChIP-seq demonstrates STAT5 and NFIB bind composite regulatory elements with H3K4me2 enhancer marks and progesterone receptor binding; combined absence of NFIB and STAT5 prevents functional alveoli formation, whereas NFIB alone is not required for alveolar expansion.","method":"Mammary-specific conditional Nfib KO, ChIP-seq (NFIB and STAT5), gene expression analysis","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP-seq establishing co-occupancy at enhancers, conditional double KO with defined mammary phenotype","pmids":["24678731"],"is_preprint":false},{"year":2017,"finding":"NFIB acts downstream of BRN2 in melanoma to promote migration and invasion via upregulation of the polycomb protein EZH2; NFIB-driven EZH2 upregulation leads to decreased MITF expression, shifting cells to a less proliferative, more invasive phenotype.","method":"Knockdown/overexpression in melanoma cells, migration/invasion assays, western blot, gene expression analysis","journal":"EBioMedicine","confidence":"Medium","confidence_rationale":"Tier 2–3 — functional KD/OE with defined pathway placement (BRN2→NFIB→EZH2→MITF), single lab","pmids":["28119061"],"is_preprint":false},{"year":2017,"finding":"NFIB directly interacts with the CDKN1A (p21) promoter in TP53-mutated TNBC cells to suppress p21 transcription; NFIB knockdown induces p21 upregulation, cell death, and cell cycle arrest, and double knockdown of p21 and NFIB reverses docetaxel-induced growth inhibition, establishing p21 as a key mediator of NFIB's pro-survival, drug-resistance function.","method":"ChIP (NFIB binding to CDKN1A promoter), siRNA knockdown, double knockdown rescue experiment, drug sensitivity assays","journal":"The Journal of pathology","confidence":"High","confidence_rationale":"Tier 1–2 — direct ChIP evidence of promoter occupancy plus genetic epistasis via double knockdown rescue","pmids":["30350349"],"is_preprint":false},{"year":2015,"finding":"In androgen-dependent LNCaP prostate cancer cells, 64.3% of NFIB ChIP-seq binding sites overlap with AR and FOXA1 binding sites; NFIB knockdown increases AR expression and superinduces a subset of AR target genes; loss of Nfib in mouse prostate (renal capsule engraftment model) results in prostatic hyperplasia not resolved by castration, suggesting NFIB is a coregulator of AR action.","method":"ChIP-seq (NFIB in LNCaP cells), siRNA knockdown, Nfib KO prostatic renal capsule engraftment","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1–2 — genome-wide ChIP-seq, functional KD, in vivo engraftment model with defined phenotype","pmids":["26677878"],"is_preprint":false},{"year":2021,"finding":"NFIB directly upregulates ERO1A transcription, which enhances HIF1α-VEGFA-mediated angiogenesis to promote metastatic colonization; NFIB overexpression alone (via piggyBac transposon screen) is sufficient to enhance primary mammary tumor growth and lung metastatic colonization.","method":"PiggyBac transposon mutagenesis screen, NFIB overexpression in mammary tumor cells, in vivo metastasis assays, mechanistic follow-up on ERO1A-HIF1α-VEGFA pathway","journal":"EMBO molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 — in vivo gain-of-function with defined downstream pathway, single lab","pmids":["33751828"],"is_preprint":false},{"year":2017,"finding":"NFIB transcriptionally activates Nfix expression in spinal cord; in the absence of Nfia or Nfib, spinal cord NFIX expression is markedly reduced, and NFIB can activate the Nfix promoter in vitro, demonstrating a hierarchical auto-regulatory transcriptional program within the NFI family during spinal cord gliogenesis.","method":"Nfia/Nfib knockout mouse spinal cord analysis, in vitro promoter reporter assay","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2–3 — KO phenotype plus in vitro promoter assay, single lab","pmids":["29106906"],"is_preprint":false},{"year":2017,"finding":"Combined allelic loss of Nfia and Nfib in mouse cerebral cortex reveals additive/cooperative function: NFIA and NFIB are co-expressed and form heterodimers in vivo (co-immunoprecipitation). Double homozygous KO produces more severe phenotype (increased ventricular enlargement, decreased differentiated glia and neurons) than single KO.","method":"Compound Nfia/Nfib knockout mice, co-immunoprecipitation, immunofluorescence, gene expression analysis","journal":"Brain and neuroscience advances","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP demonstrating heterodimer formation in vivo, genetic epistasis by compound KO","pmids":["32166136"],"is_preprint":false},{"year":2020,"finding":"NFIB facilitates replication licensing by associating physically with the pre-replication complex (pre-RC) in mammalian cells; NFIB increases chromatin accessibility at replication origins, binds to and opens nucleosomes (single-molecule magnetic tweezers), and promotes nucleosome eviction (TEM); NFIB deficiency alters chromosome contacts/compartments in G1 and S phase and impairs firing of early-replication domain origins.","method":"Co-immunoprecipitation (NFIB with pre-RC components), ChIP-seq/ATAC-seq, single-molecule magnetic tweezers (nucleosome binding/opening), transmission electron microscopy, Hi-C (chromosome contacts)","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — multiple biophysical methods (magnetic tweezers, TEM) plus genomic assays establishing direct interaction with pre-RC and chromatin remodeling activity","pmids":["37604829"],"is_preprint":false},{"year":2023,"finding":"CARM1 methylates NFIB, and methylated NFIB recruits TRIM29 as an effector molecule; CARM1 functions as a coactivator for NFIB-dependent transcription. In a mouse SCLC model, the CARM1 methylation site on NFIB and CARM1 itself are both critical for rapid SCLC onset; CARM1 and methylated NFIB maintain similar open chromatin states in tumors.","method":"Biochemical substrate identification, co-IP (NFIB-CARM1, NFIB-TRIM29), mouse SCLC model with methylation-site mutant NFIB, ATAC-seq","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 — biochemical identification of methylation, effector pulldown, in vivo mouse model with point mutant, chromatin profiling","pmids":["36690626"],"is_preprint":false},{"year":2022,"finding":"NFIB regulates hepatic CYP2D6 expression: NFIB inhibits CYP2D6 gene expression in Huh7 cells and 3D liver spheroids; carriers of NFIB rs28379954 T>C polymorphism have reduced NFIB expression and elevated risperidone hydroxylation rates (equivalent to CYP2D6 ultrarapid metabolizers), demonstrating NFIB as a transcriptional regulator of CYP2D6 in vivo.","method":"3D liver spheroid and Huh7 cell overexpression/inhibition, in vivo pharmacokinetic analysis in 604 patients genotyped for NFIB and CYP2D6","journal":"Clinical pharmacology and therapeutics","confidence":"High","confidence_rationale":"Tier 2 — in vitro functional assay plus large in vivo patient cohort validating regulatory mechanism","pmids":["35253216"],"is_preprint":false},{"year":2021,"finding":"NFIB directly binds the NDUFA4L2 promoter region and promotes its transcription; NFIB-upregulated NDUFA4L2 inhibits sorafenib-induced reactive oxygen species accumulation, conferring sorafenib resistance in hepatocellular carcinoma cells.","method":"ChIP (NFIB binding to NDUFA4L2 promoter), NFIB knockdown in HCC cells, ROS measurement, drug sensitivity assays","journal":"Cancer science","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP establishing direct promoter occupancy, functional KD with defined ROS/drug resistance phenotype, single lab","pmids":["36369883"],"is_preprint":false},{"year":2024,"finding":"NFIB directly binds promoters of CDH1 (E-cadherin) and VIM (vimentin) to regulate EMT-related transcription independently of canonical EMT transcription factors; NFIB protein stability in AR-negative CRPC is regulated by m6A: YTHDF2 recognizes m6A-methylated NFIB mRNA to increase its stability, while downregulation of TRIM8 (its E3 ubiquitin ligase, itself translationally reduced by m6A modification via ALKBH5 reduction) increases NFIB protein stability.","method":"ChIP (NFIB at CDH1 and VIM promoters), NFIB loss-of-function, m6A-RIP/MeRIP, YTHDF2 and TRIM8 functional studies, in vivo metastasis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP identifying direct gene targets, m6A sequencing, ubiquitin ligase identification, multiple orthogonal mechanisms in one study","pmids":["38536119"],"is_preprint":false},{"year":2021,"finding":"NFIB directly binds the PINK1 promoter and transcriptionally regulates PINK1 expression in kidney renal clear cell carcinoma, promoting tumor progression and metastasis.","method":"ChIP (NFIB at PINK1 promoter), NFIB knockdown, in vitro migration/invasion assays","journal":"PeerJ","confidence":"Medium","confidence_rationale":"Tier 2–3 — ChIP demonstrating direct promoter binding, functional KD, single lab","pmids":["33981484"],"is_preprint":false},{"year":2019,"finding":"NFIB binds the ITGA6 promoter (chromatin immunoprecipitation) in colorectal cancer cells and activates ITGA6 transcription to promote cell metastasis; miR-302a directly targets the NFIB 3'-UTR (luciferase reporter assay) to suppress this pro-metastatic NFIB→ITGA6 axis.","method":"ChIP (NFIB at ITGA6 promoter), luciferase 3'-UTR reporter assay, functional migration/invasion assays","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP establishing direct NFIB-ITGA6 promoter binding, functional assays; single lab","pmids":["31754405"],"is_preprint":false},{"year":2025,"finding":"NFIB promotes NFIB-ITGA6-driven metastasis as a direct transcriptional activator of ITGA6; separately, circHIF1A modulates NFIB expression and nuclear translocation through posttranscriptional and posttranslational mechanisms, leading to AKT/STAT3 pathway activation and p21 inhibition in TNBC; NFIB in turn transcriptionally regulates FUS, forming a circHIF1A/NFIB/FUS positive feedback loop.","method":"Gain/loss-of-function in TNBC cells and xenografts, posttranslational modification analysis, RNA-protein interaction studies","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2–3 — multiple functional experiments but mechanistic detail of posttranslational modification of NFIB not fully resolved, single lab","pmids":["33714984"],"is_preprint":false},{"year":2017,"finding":"NFIB interacts physically with the estrogen receptor ESR1-FOXA1 complex (co-immunoprecipitation) and inhibits ESR1 transactivational potential; FGFR2 signaling augments these interactions to further repress ESR1 target gene expression.","method":"Co-immunoprecipitation, gene expression reporter assays, FGFR2 signaling inhibition","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP establishing physical interaction with ESR1-FOXA1 complex, functional transcriptional assay, single lab","pmids":["29180470"],"is_preprint":false},{"year":2020,"finding":"KDM4D histone demethylase physically interacts with NFIB and MLL1 complex; KDM4D-mediated demethylation of H3K9me3 is required for NFIB and MLL1 complex to deposit H3K4me3 and activate PPARγ and C/EBPα expression during adipogenesis, placing NFIB in a defined chromatin-remodeling hierarchy for adipogenic differentiation.","method":"Co-IP (KDM4D-NFIB-MLL1), ChIP (NFIB and MLL1 at target promoters), KDM4D KD/rescue in C3H10T1/2 cells","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP and ChIP establishing physical and functional interaction in chromatin context, single lab","pmids":["32080306"],"is_preprint":false},{"year":2015,"finding":"HIV-1 infection induces NF-IB (NFIB) expression, and NFIB associates with the HIV-1 long terminal repeat (LTR) region (−386 to −453 nt) as shown by ChIP assay; this association negatively correlates with HIV-1 transcription. NFIB knockdown increases HIV-1 replication in latently infected cells, indicating a repressive role of NFIB at the LTR.","method":"ChIP assay (NFIB at HIV-1 LTR), siRNA knockdown of NFIB in J1.1 and J-Lat cells, viral replication measurement","journal":"Viruses","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP establishing direct LTR binding, functional KD with viral replication readout, single lab","pmids":["25664610"],"is_preprint":false},{"year":2021,"finding":"NFIB overexpression in hPSC-derived neural precursor cells induces differentiation into functional astrocytes within 2 weeks, recapitulating in vivo astrogliogenesis transcriptomically and physiologically; the MAPK pathway is necessary for NFIB-driven astrocyte differentiation.","method":"NFIB overexpression in hPSC-derived NPCs, RNA-seq, functional astrocyte assays, MAPK pathway inhibition","journal":"Journal of cellular physiology","confidence":"Medium","confidence_rationale":"Tier 2–3 — defined differentiation phenotype with transcriptomic validation and pathway identification, single lab","pmids":["33949692"],"is_preprint":false},{"year":2024,"finding":"Using conditional gene knockout in SCLC GEMMs, NFIB upregulation contributes to tumor progression but is not strictly required for metastasis; FOXA1/2 pioneer transcription factors were identified as candidate drivers of metastasis in NFIB-knockout SCLC tumors, revealing SCLC plasticity and NFIB-independent metastatic mechanisms.","method":"Conditional Nfib knockout in SCLC GEMMs, molecular profiling of NFIB WT vs. KO tumors, identification of FOXA1/2 as compensatory factors","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — conditional KO in relevant in vivo GEMM, molecular identification of compensatory pathway","pmids":["37963187"],"is_preprint":false},{"year":2014,"finding":"NFIB ChIP-seq in mouse lung at E16.5 shows NFIB binds the NFI consensus motif in vivo; this motif is over-represented in promoters of genes under-expressed in Nfib-KO lung at E18.5, indicating NFIB acts as a transcriptional activator of lung maturation genes; 52 genes are co-regulated by NFIB and the glucocorticoid receptor (Nr3c1), overlapping 13.1-fold above chance.","method":"ChIP-seq (NFIB in lung E16.5), microarray (Nfib-KO and Nr3c1-KO), motif analysis","journal":"BMC genomics","confidence":"Medium","confidence_rationale":"Tier 2 — genome-wide ChIP-seq with KO transcriptome integration, single lab","pmids":["24661679"],"is_preprint":false},{"year":1998,"finding":"NFIB is identified as a recurrent translocation partner gene of HMGIC (HMGA2) in pleomorphic adenomas of the salivary glands; 3'-RACE and RT-PCR analyses reveal chimeric transcripts where the last five amino acids of NFIB replace the carboxy-terminal segment of HMGIC, established in two independent adenoma cases.","method":"3'-RACE analysis, RT-PCR, nucleotide sequencing of fusion transcripts","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 — direct molecular characterization of fusion transcript in two independent tumors; foundational gene fusion discovery","pmids":["9484777"],"is_preprint":false},{"year":2009,"finding":"The t(6;9)(q22-23;p23-24) translocation in adenoid cystic carcinoma creates MYB-NFIB fusion transcripts predominantly consisting of MYB exon 14 linked to the last coding exon(s) of NFIB; the minimal deleted region includes MYB exon 15/3'-UTR containing conserved miR-15a/16 and miR-150 target sites, suggesting loss of miRNA-mediated repression of MYB leads to MYB-NFIB overexpression and activation of MYB target genes.","method":"RT-PCR, nucleotide sequencing, forced miRNA overexpression in primary ACC cells, molecular characterization of translocation breakpoints","journal":"Proceedings of the National Academy of Sciences","confidence":"High","confidence_rationale":"Tier 2 — original molecular characterization of MYB-NFIB fusion with mechanistic miRNA experiment, foundational study with 624 citations","pmids":["19841262"],"is_preprint":false},{"year":2020,"finding":"In pleomorphic adenomas, NFIB fusions with PLAG1 (NFIB-PLAG1) and HMGA2 result in activation of PLAG1 and HMGA2 through promoter swapping; analysis of the NFIB chromatin landscape reveals super-enhancers in the 5'- and 3'-parts of the NFIB locus, suggesting PLAG1 and HMGA2 are activated by enhancer-hijacking events in which NFIB super-enhancers are translocated upstream of these oncogenes.","method":"RNA-seq, RT-PCR (fusion transcript identification), chromatin landscape analysis (super-enhancer identification)","journal":"Genes, chromosomes & cancer","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct fusion transcript identification plus chromatin landscape analysis; enhancer-hijacking mechanism is inferential without direct functional test","pmids":["32654217"],"is_preprint":false},{"year":2023,"finding":"NFIB downregulates miR-182-5p, which directly targets NAMPT (the rate-limiting enzyme of NAD+ salvage synthesis); this NFIB→miR-182-5p→NAMPT axis promotes NAD+ production and colorectal cancer cell proliferation; NAD+ precursor NMN supplementation rescues proliferation in NFIB-knockdown cells.","method":"NFIB KD/OE in CRC cells, miRNA profiling, luciferase 3'-UTR reporter (miR-182-5p→NAMPT), NAD+ measurement, NMN rescue","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2–3 — functional pathway defined with metabolic rescue, single lab","pmids":["37491379"],"is_preprint":false}],"current_model":"NFIB is a multifunctional nuclear factor I family transcription factor that binds the NFI consensus motif to directly activate or repress target gene promoters (including Ezh2, CDKN1A/p21, NDUFA4L2, PINK1, ITGA6, NAMPT, CYP2D6, and Edn2), forms homodimers and heterodimers (including with NFIA) as well as complexes with STAT5, CARM1, AR/FOXA1, ESR1-FOXA1, and the pre-replication complex, undergoes CARM1-mediated arginine methylation that recruits TRIM29 to coactivate transcription and is regulated by YTHDF2-dependent m6A mRNA stabilization and TRIM8-mediated ubiquitination; it increases chromatin accessibility genome-wide by binding and opening nucleosomes to facilitate replication origin firing and to drive metastatic gene expression programs, and is essential in vivo for lung maturation, corpus callosum formation, hippocampal and pontine development, and astrocytic differentiation, while being hijacked as an oncogenic fusion partner (MYB-NFIB, HMGA2-NFIB, PLAG1-NFIB, MYBL1-NFIB) in multiple cancer types."},"narrative":{"teleology":[{"year":1997,"claim":"The discovery that a truncated NFIB isoform (NFI-B3) acts as a dominant-negative by heterodimerizing with full-length NFI proteins established that NFIB functions through dimerization-dependent DNA binding and that alternative splicing generates regulatory diversity within the NFI family.","evidence":"Reconstitution in NFI-null Drosophila SL-2 cells with EMSA and transcription assays","pmids":["9099724"],"confidence":"High","gaps":["Crystal structure of NFIB homodimer/heterodimer not determined","In vivo relevance of NFI-B3 dominant-negative isoform not tested"]},{"year":1998,"claim":"Identification of HMGA2-NFIB fusion transcripts in pleomorphic adenomas revealed that the NFIB locus is a recurrent translocation target in salivary gland tumors, later extended to MYB-NFIB in adenoid cystic carcinoma and PLAG1-NFIB fusions.","evidence":"3'-RACE and RT-PCR in two independent pleomorphic adenoma cases; MYB-NFIB fusion characterized by RT-PCR and sequencing in ACC","pmids":["9484777","19841262","32654217"],"confidence":"High","gaps":["Direct functional consequence of NFIB sequences in chimeric proteins not fully resolved","Enhancer-hijacking mechanism for NFIB super-enhancers inferred but not functionally validated by deletion"]},{"year":2002,"claim":"Nfib knockout mice dying perinatally with severe lung hypoplasia and failure to downregulate TGF-β1/Shh established NFIB as essential for late fetal lung maturation, answering whether any single NFI family member is non-redundant in organogenesis.","evidence":"Nfib-null mouse with histology, immunostaining, and in situ hybridization","pmids":["11850179"],"confidence":"High","gaps":["Direct transcriptional targets mediating lung saccularization were not identified in this study","Whether NFIB represses TGF-β1/Shh directly or indirectly was unresolved"]},{"year":2005,"claim":"Expanded phenotyping of Nfib-null mice revealed callosal agenesis, hippocampal defects, and basilar pons malformation — more severe than Nfia loss — establishing NFIB as the predominant NFI member in forebrain and hindbrain development.","evidence":"Nfib knockout with histological and anatomical analysis; Nfib-specific pontine phenotype confirmed by comparison with Nfia/Nfix nulls","pmids":["15632069","19107796","19961580"],"confidence":"High","gaps":["Cell-autonomous vs. non-cell-autonomous contributions initially unclear (partially resolved for corpus callosum by PMID:19961580)","Downstream transcriptional targets in brain not yet identified"]},{"year":2013,"claim":"Conditional Nfib knockout in hair follicle stem cells, combined with ChIP-seq, identified Edn2 as a direct NFIB target whose ectopic activation drives premature melanocyte stem cell differentiation — the first demonstration that NFIB coordinates inter-lineage stem cell niche signaling.","evidence":"Conditional KO mouse, ChIP-seq, pharmacological rescue with endothelin receptor antagonists and KIT-blocking antibodies","pmids":["23389444"],"confidence":"High","gaps":["Whether NFIB directly represses or indirectly controls Edn2 chromatin state not fully dissected","Relevance to human hair graying not demonstrated"]},{"year":2014,"claim":"ChIP and reporter assays showed NFIB directly binds and represses the Ezh2 promoter, limiting neural progenitor self-renewal; genome-wide ChIP-seq in fetal lung confirmed NFIB recognizes the NFI consensus motif in vivo and co-regulates genes with the glucocorticoid receptor, defining NFIB's dual role as a direct activator and repressor.","evidence":"ChIP/ChIP-seq in brain and lung, Nfib-KO microarray, overexpression reporter assays","pmids":["24553933","24661679"],"confidence":"High","gaps":["Genome-wide activator vs. repressor target classification incomplete","Mechanism of context-dependent switching between activation and repression unknown"]},{"year":2014,"claim":"ChIP-seq in mammary epithelium revealed NFIB co-occupies enhancers with STAT5, and combined Nfib/Stat5 loss prevents alveolar function, establishing NFIB as a tissue-specific cofactor that collaborates with lineage-determining transcription factors at enhancers.","evidence":"Mammary conditional Nfib KO, ChIP-seq for NFIB and STAT5, gene expression analysis","pmids":["24678731"],"confidence":"High","gaps":["Whether NFIB directly interacts with STAT5 protein was not shown by co-IP in this study","Mechanism of enhancer selection by NFIB-STAT5 unknown"]},{"year":2015,"claim":"ChIP-seq in prostate cancer cells demonstrated extensive NFIB co-binding with AR and FOXA1 at regulatory elements, and Nfib loss caused castration-resistant prostatic hyperplasia, revealing NFIB as a coregulator that restrains androgen receptor signaling.","evidence":"ChIP-seq in LNCaP cells, siRNA knockdown, Nfib-KO prostatic engraftment in vivo","pmids":["26677878"],"confidence":"High","gaps":["Direct physical interaction between NFIB and AR not shown by co-IP","Mechanism by which NFIB restrains AR target gene expression unresolved"]},{"year":2016,"claim":"Three independent studies in SCLC mouse models converged to show that NFIB amplification/overexpression drives metastasis by opening distal chromatin at thousands of regulatory elements genome-wide, establishing NFIB as a chromatin accessibility factor — not merely a classical transcription factor — that enables metastatic gene programs.","evidence":"ATAC-seq, NFIB KD/OE, in vivo metastasis assays in Rb1/Trp53-deleted GEMMs","pmids":["27374332","27373156","27613844"],"confidence":"High","gaps":["Biophysical mechanism of chromatin opening not yet determined (resolved later in 2020)","Whether NFIB is strictly required for metastasis or can be compensated was unresolved"]},{"year":2016,"claim":"Discovery that Drosha directly destabilizes NFIB mRNA independently of Dicer/miRNAs to restrict oligodendrocyte fate in adult hippocampal stem cells established a non-canonical post-transcriptional control layer for NFIB levels during cell fate decisions.","evidence":"Conditional Drosha KO in adult NSCs, NFIB knockdown rescue, lineage tracing","pmids":["27545503"],"confidence":"High","gaps":["Drosha cleavage site on NFIB mRNA not mapped","Whether this mechanism operates outside hippocampus unknown"]},{"year":2017,"claim":"Multiple studies expanded NFIB's transcriptional network: NFIB activates NFIX in spinal cord gliogenesis (establishing NFI family hierarchy), forms heterodimers with NFIA in vivo (co-IP), interacts with ESR1-FOXA1 to repress estrogen receptor signaling, and in melanoma acts downstream of BRN2 to upregulate EZH2.","evidence":"Compound Nfia/Nfib KO, co-IP, promoter reporter assays, KD/OE in melanoma and breast cancer cells","pmids":["29106906","32166136","29180470","28119061"],"confidence":"Medium","gaps":["Heterodimer stoichiometry and DNA-binding preference differences between NFIB homodimers and NFIA-NFIB heterodimers not characterized","NFIB context-dependent switch from Ezh2 repressor (brain) to EZH2 activator (melanoma) mechanistically unexplained"]},{"year":2018,"claim":"ChIP demonstrated NFIB directly occupies the CDKN1A (p21) promoter in TP53-mutant TNBC; double knockdown of p21 and NFIB rescued docetaxel sensitivity, establishing p21 as a critical downstream effector of NFIB-mediated drug resistance.","evidence":"ChIP, siRNA single and double knockdown, drug sensitivity assays in TNBC cells","pmids":["30350349"],"confidence":"High","gaps":["Whether NFIB repression of p21 requires TP53 mutation context not tested in TP53-WT cells","Generalizability to other chemotherapeutic agents not established"]},{"year":2020,"claim":"Single-molecule magnetic tweezers and TEM revealed NFIB directly binds and opens nucleosomes, and co-IP showed it associates with pre-replication complex components; NFIB deficiency altered replication origin firing and 3D chromosome compartments, unifying NFIB's chromatin remodeling and replication licensing activities.","evidence":"Magnetic tweezers, TEM, co-IP with pre-RC, ChIP-seq/ATAC-seq, Hi-C in mammalian cells","pmids":["37604829"],"confidence":"High","gaps":["Whether nucleosome opening is catalytic or stoichiometric not determined","Structural basis of NFIB-nucleosome interaction unknown","Relative contribution of replication vs. transcription functions to metastasis not separated"]},{"year":2023,"claim":"Identification of CARM1 as a methyltransferase for NFIB, with methylated NFIB recruiting TRIM29, established the first defined post-translational modification-effector axis for NFIB; in vivo, a methylation-site mutant delayed SCLC onset as severely as CARM1 loss.","evidence":"Biochemical substrate identification, co-IP, ATAC-seq, mouse SCLC model with NFIB methylation-site point mutant","pmids":["36690626"],"confidence":"High","gaps":["TRIM29's effector mechanism at NFIB target sites not defined","Whether CARM1-NFIB axis operates outside SCLC unknown"]},{"year":2024,"claim":"Discovery that YTHDF2 stabilizes m6A-modified NFIB mRNA while TRIM8 ubiquitinates NFIB protein for degradation provided dual epitranscriptomic/proteasomal control of NFIB levels, and conditional Nfib KO in SCLC GEMMs revealed FOXA1/2 can compensate for NFIB loss in driving metastasis.","evidence":"m6A-RIP, YTHDF2/TRIM8 functional studies, conditional Nfib KO in SCLC GEMM with molecular profiling","pmids":["38536119","37963187"],"confidence":"High","gaps":["Whether YTHDF2-NFIB and TRIM8-NFIB axes interact or are independent pathways not tested","FOXA1/2 compensation mechanism and whether it requires chromatin opening activity unknown"]},{"year":null,"claim":"Key unresolved questions include the structural basis of NFIB's nucleosome-opening activity, how the same factor switches between transcriptional activation and repression in different tissues, and whether NFIB's replication licensing and transcriptional functions are mechanistically separable.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No high-resolution structure of NFIB bound to nucleosome or DNA","Context-dependent activation vs. repression mechanism unknown","Replication vs. transcription functions not genetically separated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2,6,7,13,14,18,31]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,5,6,13,16,20,21,24,31]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[18]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[6,7,14,18,31]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[18]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,5,6,7,13,14,16,20,21,24,31]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[7,18,19]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[18]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,3,4,5,6,10,29]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[18]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[7,8,9,33]}],"complexes":["NFI homodimer/heterodimer","pre-replication complex (pre-RC)"],"partners":["NFIA","STAT5","CARM1","TRIM29","FOXA1","ESR1","KDM4D","TRIM8"],"other_free_text":[]},"mechanistic_narrative":"NFIB is a nuclear factor I (NFI) family transcription factor that binds the NFI consensus motif as homodimers or heterodimers (with NFIA) to activate or repress diverse target gene promoters, thereby orchestrating lung maturation, brain development, gliogenesis, and chromatin accessibility programs [PMID:15632069, PMID:9099724, PMID:32166136]. NFIB directly binds and opens nucleosomes to increase chromatin accessibility at replication origins and distal regulatory elements, facilitating replication licensing through association with the pre-replication complex and driving metastatic gene expression programs in small cell lung cancer [PMID:37604829, PMID:27374332]. It directly regulates transcription of targets including Ezh2, CDKN1A/p21, Edn2, NDUFA4L2, ITGA6, PINK1, CYP2D6, and NFIX, and is itself regulated post-transcriptionally by Drosha-mediated mRNA cleavage, YTHDF2-dependent m6A stabilization, and TRIM8-mediated ubiquitination, while serving as a CARM1 methylation substrate that recruits TRIM29 for transcriptional coactivation [PMID:24553933, PMID:13889444, PMID:30350349, PMID:27545503, PMID:38536119, PMID:36690626]. NFIB is recurrently hijacked as a fusion partner (MYB-NFIB, HMGA2-NFIB, PLAG1-NFIB) in adenoid cystic carcinoma and pleomorphic adenoma, where its super-enhancers drive oncogene activation through enhancer hijacking [PMID:19841262, PMID:9484777, PMID:32654217]."},"prefetch_data":{"uniprot":{"accession":"O00712","full_name":"Nuclear factor 1 B-type","aliases":["CCAAT-box-binding transcription factor","CTF","Nuclear factor I/B","NF-I/B","NFI-B","TGGCA-binding protein"],"length_aa":420,"mass_kda":47.4,"function":"Transcriptional activator of GFAP, essential for proper brain development (PubMed:30388402). Recognizes and binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the origin of replication of adenovirus type 2. These proteins are individually capable of activating transcription and replication","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/O00712/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NFIB","classification":"Not Classified","n_dependent_lines":22,"n_total_lines":1208,"dependency_fraction":0.018211920529801324},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NFIB","total_profiled":1310},"omim":[{"mim_id":"618286","title":"MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID","url":"https://www.omim.org/entry/618286"},{"mim_id":"600729","title":"NUCLEAR FACTOR I/C; NFIC","url":"https://www.omim.org/entry/600729"},{"mim_id":"600728","title":"NUCLEAR FACTOR I/B; NFIB","url":"https://www.omim.org/entry/600728"},{"mim_id":"600727","title":"NUCLEAR FACTOR I/A; NFIA","url":"https://www.omim.org/entry/600727"},{"mim_id":"164005","title":"NUCLEAR FACTOR I/X; NFIX","url":"https://www.omim.org/entry/164005"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli fibrillar center","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NFIB"},"hgnc":{"alias_symbol":["NFI-RED","NFIB2","NFIB3"],"prev_symbol":[]},"alphafold":{"accession":"O00712","domains":[{"cath_id":"3.90.520.10","chopping":"6-172","consensus_level":"high","plddt":93.5719,"start":6,"end":172}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O00712","model_url":"https://alphafold.ebi.ac.uk/files/AF-O00712-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O00712-F1-predicted_aligned_error_v6.png","plddt_mean":67.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NFIB","jax_strain_url":"https://www.jax.org/strain/search?query=NFIB"},"sequence":{"accession":"O00712","fasta_url":"https://rest.uniprot.org/uniprotkb/O00712.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O00712/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O00712"}},"corpus_meta":[{"pmid":"19841262","id":"PMC_19841262","title":"Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19841262","citation_count":624,"is_preprint":false},{"pmid":"27374332","id":"PMC_27374332","title":"Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/27374332","citation_count":297,"is_preprint":false},{"pmid":"21572406","id":"PMC_21572406","title":"Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.","date":"2011","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/21572406","citation_count":275,"is_preprint":false},{"pmid":"15632069","id":"PMC_15632069","title":"The transcription factor gene Nfib is essential for both lung maturation and brain development.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15632069","citation_count":251,"is_preprint":false},{"pmid":"20702610","id":"PMC_20702610","title":"Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.","date":"2010","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/20702610","citation_count":237,"is_preprint":false},{"pmid":"2339052","id":"PMC_2339052","title":"Chicken NFI/TGGCA proteins are encoded by at least three independent genes: NFI-A, NFI-B and NFI-C with homologues in mammalian genomes.","date":"1990","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/2339052","citation_count":172,"is_preprint":false},{"pmid":"26631609","id":"PMC_26631609","title":"Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.","date":"2015","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/26631609","citation_count":168,"is_preprint":false},{"pmid":"23389444","id":"PMC_23389444","title":"NFIB is a governor of epithelial-melanocyte stem cell behaviour in a shared niche.","date":"2013","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23389444","citation_count":141,"is_preprint":false},{"pmid":"21976542","id":"PMC_21976542","title":"Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome.","date":"2011","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/21976542","citation_count":124,"is_preprint":false},{"pmid":"22505352","id":"PMC_22505352","title":"Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma.","date":"2012","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/22505352","citation_count":124,"is_preprint":false},{"pmid":"27373156","id":"PMC_27373156","title":"Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27373156","citation_count":122,"is_preprint":false},{"pmid":"9484777","id":"PMC_9484777","title":"Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas.","date":"1998","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/9484777","citation_count":121,"is_preprint":false},{"pmid":"33714984","id":"PMC_33714984","title":"CircHIF1A regulated by FUS accelerates triple-negative breast cancer progression by modulating NFIB expression and translocation.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/33714984","citation_count":86,"is_preprint":false},{"pmid":"11850179","id":"PMC_11850179","title":"Nuclear factor I-B (Nfib) deficient mice have severe lung hypoplasia.","date":"2002","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11850179","citation_count":85,"is_preprint":false},{"pmid":"26084801","id":"PMC_26084801","title":"A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.","date":"2015","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/26084801","citation_count":84,"is_preprint":false},{"pmid":"21618541","id":"PMC_21618541","title":"The MYB-NFIB gene fusion-a novel genetic link between adenoid cystic carcinoma and dermal cylindroma.","date":"2011","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21618541","citation_count":84,"is_preprint":false},{"pmid":"27545503","id":"PMC_27545503","title":"Multipotency of Adult Hippocampal NSCs In Vivo Is Restricted by Drosha/NFIB.","date":"2016","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/27545503","citation_count":79,"is_preprint":false},{"pmid":"29149504","id":"PMC_29149504","title":"MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.","date":"2017","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/29149504","citation_count":78,"is_preprint":false},{"pmid":"31754405","id":"PMC_31754405","title":"miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31754405","citation_count":75,"is_preprint":false},{"pmid":"25217885","id":"PMC_25217885","title":"MYB-NFIB gene fusion in adenoid cystic carcinoma of the breast with special focus paid to the solid variant with basaloid features.","date":"2014","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25217885","citation_count":75,"is_preprint":false},{"pmid":"28119061","id":"PMC_28119061","title":"NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.","date":"2017","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/28119061","citation_count":72,"is_preprint":false},{"pmid":"24553933","id":"PMC_24553933","title":"NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development.","date":"2014","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24553933","citation_count":69,"is_preprint":false},{"pmid":"24949940","id":"PMC_24949940","title":"miR-365 promotes cutaneous squamous cell carcinoma (CSCC) through targeting nuclear factor I/B (NFIB).","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24949940","citation_count":67,"is_preprint":false},{"pmid":"28594149","id":"PMC_28594149","title":"MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.","date":"2017","source":"Histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/28594149","citation_count":65,"is_preprint":false},{"pmid":"29180470","id":"PMC_29180470","title":"ERα Binding by Transcription Factors NFIB and YBX1 Enables FGFR2 Signaling to Modulate Estrogen Responsiveness in Breast Cancer.","date":"2017","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/29180470","citation_count":64,"is_preprint":false},{"pmid":"27613844","id":"PMC_27613844","title":"NFIB overexpression cooperates with Rb/p53 deletion to promote small cell lung cancer.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27613844","citation_count":61,"is_preprint":false},{"pmid":"19961580","id":"PMC_19961580","title":"Multiple non-cell-autonomous defects underlie neocortical callosal dysgenesis in Nfib-deficient mice.","date":"2009","source":"Neural development","url":"https://pubmed.ncbi.nlm.nih.gov/19961580","citation_count":53,"is_preprint":false},{"pmid":"21925980","id":"PMC_21925980","title":"NFIB is a potential target for estrogen receptor-negative breast cancers.","date":"2011","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21925980","citation_count":52,"is_preprint":false},{"pmid":"29106906","id":"PMC_29106906","title":"Transcriptional regulation of Nfix by NFIB drives astrocytic maturation within the developing spinal cord.","date":"2017","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/29106906","citation_count":50,"is_preprint":false},{"pmid":"25591821","id":"PMC_25591821","title":"p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB.","date":"2015","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/25591821","citation_count":49,"is_preprint":false},{"pmid":"9099724","id":"PMC_9099724","title":"NFI-B3, a novel transcriptional repressor of the nuclear factor I family, is generated by alternative RNA processing.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9099724","citation_count":48,"is_preprint":false},{"pmid":"23161775","id":"PMC_23161775","title":"MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2.","date":"2012","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23161775","citation_count":48,"is_preprint":false},{"pmid":"30388402","id":"PMC_30388402","title":"NFIB Haploinsufficiency Is Associated with Intellectual Disability and Macrocephaly.","date":"2018","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30388402","citation_count":45,"is_preprint":false},{"pmid":"28645739","id":"PMC_28645739","title":"miR-1224 inhibits cell proliferation in acute liver failure by targeting the antiapoptotic gene Nfib.","date":"2017","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/28645739","citation_count":43,"is_preprint":false},{"pmid":"27357447","id":"PMC_27357447","title":"Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma.","date":"2016","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27357447","citation_count":42,"is_preprint":false},{"pmid":"33751828","id":"PMC_33751828","title":"The NFIB-ERO1A axis promotes breast cancer metastatic colonization of disseminated tumour cells.","date":"2021","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33751828","citation_count":42,"is_preprint":false},{"pmid":"30350349","id":"PMC_30350349","title":"NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.","date":"2018","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/30350349","citation_count":41,"is_preprint":false},{"pmid":"34466790","id":"PMC_34466790","title":"YAP regulates alveolar epithelial cell differentiation and AGER via NFIB/KLF5/NKX2-1.","date":"2021","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/34466790","citation_count":40,"is_preprint":false},{"pmid":"38536119","id":"PMC_38536119","title":"m6A Modification Promotes EMT and Metastasis of Castration-Resistant Prostate Cancer by Upregulating NFIB.","date":"2024","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/38536119","citation_count":39,"is_preprint":false},{"pmid":"33061846","id":"PMC_33061846","title":"Hsa_circ_0026416 promotes proliferation and migration in colorectal cancer via miR-346/NFIB axis.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/33061846","citation_count":38,"is_preprint":false},{"pmid":"16133369","id":"PMC_16133369","title":"Fusion of the HMGA2 and NFIB genes in lipoma.","date":"2005","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16133369","citation_count":36,"is_preprint":false},{"pmid":"11346465","id":"PMC_11346465","title":"A novel amplicon at 9p23 - 24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB.","date":"2001","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/11346465","citation_count":36,"is_preprint":false},{"pmid":"27083054","id":"PMC_27083054","title":"Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27083054","citation_count":36,"is_preprint":false},{"pmid":"36690626","id":"PMC_36690626","title":"The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36690626","citation_count":33,"is_preprint":false},{"pmid":"18663748","id":"PMC_18663748","title":"NFIB rearrangement in superficial, retroperitoneal, and colonic lipomas with aberrations involving chromosome band 9p22.","date":"2008","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18663748","citation_count":31,"is_preprint":false},{"pmid":"35253216","id":"PMC_35253216","title":"The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients.","date":"2022","source":"Clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/35253216","citation_count":30,"is_preprint":false},{"pmid":"31838646","id":"PMC_31838646","title":"Common Regulatory Targets of NFIA, NFIX and NFIB during Postnatal Cerebellar Development.","date":"2020","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31838646","citation_count":29,"is_preprint":false},{"pmid":"30527239","id":"PMC_30527239","title":"UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line.","date":"2018","source":"Oral oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30527239","citation_count":28,"is_preprint":false},{"pmid":"32166136","id":"PMC_32166136","title":"Combined allelic dosage of Nfia and Nfib regulates cortical development.","date":"2017","source":"Brain and neuroscience advances","url":"https://pubmed.ncbi.nlm.nih.gov/32166136","citation_count":27,"is_preprint":false},{"pmid":"19837271","id":"PMC_19837271","title":"HMGA2-NFIB fusion in a pediatric intramuscular lipoma: a novel case of NFIB alteration in a large deep-seated adipocytic tumor.","date":"2009","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19837271","citation_count":27,"is_preprint":false},{"pmid":"31807116","id":"PMC_31807116","title":"MicroRNA-346 inhibits the growth of glioma by directly targeting NFIB.","date":"2019","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/31807116","citation_count":26,"is_preprint":false},{"pmid":"30015981","id":"PMC_30015981","title":"NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the Akt/Stat3 signaling pathway.","date":"2018","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/30015981","citation_count":26,"is_preprint":false},{"pmid":"27662035","id":"PMC_27662035","title":"Frequent NFIB-associated Gene Rearrangement in Adenoid Cystic Carcinoma of the Vulva.","date":"2017","source":"International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists","url":"https://pubmed.ncbi.nlm.nih.gov/27662035","citation_count":24,"is_preprint":false},{"pmid":"19107796","id":"PMC_19107796","title":"Absence of the transcription factor Nfib delays the formation of the basilar pontine and other mossy fiber nuclei.","date":"2009","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/19107796","citation_count":24,"is_preprint":false},{"pmid":"26677878","id":"PMC_26677878","title":"Nfib Regulates Transcriptional Networks That Control the Development of Prostatic Hyperplasia.","date":"2015","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/26677878","citation_count":24,"is_preprint":false},{"pmid":"32706064","id":"PMC_32706064","title":"Long non-coding RNA OIP5-AS1 plays an oncogenic role in ovarian cancer through targeting miR-324-3p/NFIB axis.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32706064","citation_count":21,"is_preprint":false},{"pmid":"32080306","id":"PMC_32080306","title":"Histone demethylase KDM4D cooperates with NFIB and MLL1 complex to regulate adipogenic differentiation of C3H10T1/2 mesenchymal stem cells.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32080306","citation_count":20,"is_preprint":false},{"pmid":"32659236","id":"PMC_32659236","title":"Regulatory effect of LncRNA DRAIC/miR-149-5p/NFIB molecular network on autophagy of esophageal cancer cells and its biological behavior.","date":"2020","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/32659236","citation_count":20,"is_preprint":false},{"pmid":"34267816","id":"PMC_34267816","title":"lncRNA LOXL1-AS1 promotes liver cancer cell proliferation and migration by regulating the miR-377-3p/NFIB axis.","date":"2021","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/34267816","citation_count":20,"is_preprint":false},{"pmid":"36369883","id":"PMC_36369883","title":"Transcriptional regulation of NDUFA4L2 by NFIB induces sorafenib resistance by decreasing reactive oxygen species in hepatocellular carcinoma.","date":"2022","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/36369883","citation_count":20,"is_preprint":false},{"pmid":"35565392","id":"PMC_35565392","title":"Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/35565392","citation_count":19,"is_preprint":false},{"pmid":"31760595","id":"PMC_31760595","title":"Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.","date":"2019","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31760595","citation_count":19,"is_preprint":false},{"pmid":"28861760","id":"PMC_28861760","title":"Non-small cell lung cancer: miR-30d suppresses tumor invasion and migration by directly targeting NFIB.","date":"2017","source":"Biotechnology letters","url":"https://pubmed.ncbi.nlm.nih.gov/28861760","citation_count":19,"is_preprint":false},{"pmid":"31908480","id":"PMC_31908480","title":"LncRNA LINC00461 Promotes Colorectal Cancer Progression via miRNA-323b-3p/NFIB Axis.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31908480","citation_count":19,"is_preprint":false},{"pmid":"33013202","id":"PMC_33013202","title":"MicroRNA-138-5p targets the NFIB-Snail1 axis to inhibit colorectal cancer cell migration and chemoresistance.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/33013202","citation_count":19,"is_preprint":false},{"pmid":"32654217","id":"PMC_32654217","title":"Activation of PLAG1 and HMGA2 by gene fusions involving the transcriptional regulator gene NFIB.","date":"2020","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32654217","citation_count":19,"is_preprint":false},{"pmid":"25403566","id":"PMC_25403566","title":"NFIB regulates embryonic development of submandibular glands.","date":"2014","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/25403566","citation_count":19,"is_preprint":false},{"pmid":"21901247","id":"PMC_21901247","title":"Studies of genomic imbalances and the MYB-NFIB gene fusion in polymorphous low-grade adenocarcinoma of the head and neck.","date":"2011","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/21901247","citation_count":19,"is_preprint":false},{"pmid":"34541682","id":"PMC_34541682","title":"CircATL2 enhances paclitaxel resistance of ovarian cancer via impacting miR-506-3p/NFIB axis.","date":"2021","source":"Drug development research","url":"https://pubmed.ncbi.nlm.nih.gov/34541682","citation_count":18,"is_preprint":false},{"pmid":"33949692","id":"PMC_33949692","title":"NFIB induces functional astrocytes from human pluripotent stem cell-derived neural precursor cells mimicking in vivo astrogliogenesis.","date":"2021","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33949692","citation_count":18,"is_preprint":false},{"pmid":"36730637","id":"PMC_36730637","title":"Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis.","date":"2022","source":"Anti-cancer drugs","url":"https://pubmed.ncbi.nlm.nih.gov/36730637","citation_count":17,"is_preprint":false},{"pmid":"25763778","id":"PMC_25763778","title":"Transcription factor and microRNA interactions in lung cells: an inhibitory link between NK2 homeobox 1, miR-200c and the developmental and oncogenic factors Nfib and Myb.","date":"2015","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/25763778","citation_count":17,"is_preprint":false},{"pmid":"35409172","id":"PMC_35409172","title":"Transcriptional Regulation of RIP2 Gene by NFIB Is Associated with Cellular Immune and Inflammatory Response to APEC Infection.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35409172","citation_count":16,"is_preprint":false},{"pmid":"32621625","id":"PMC_32621625","title":"LINC00319 promotes osteosarcoma progression by regulating the miR-455-3p/NFIB axis.","date":"2020","source":"The journal of gene medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32621625","citation_count":16,"is_preprint":false},{"pmid":"24678731","id":"PMC_24678731","title":"Coregulation of genetic programs by the transcription factors NFIB and STAT5.","date":"2014","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/24678731","citation_count":16,"is_preprint":false},{"pmid":"33576439","id":"PMC_33576439","title":"NFIB promotes the progression of gastric cancer by upregulating circMAP7D1 to stabilize HER2 mRNA.","date":"2021","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33576439","citation_count":16,"is_preprint":false},{"pmid":"35234989","id":"PMC_35234989","title":"Circular RNA circPTK2 modulates migration and invasion via miR-136/NFIB signaling on triple-negative breast cancer cells in vitro.","date":"2022","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/35234989","citation_count":14,"is_preprint":false},{"pmid":"34805417","id":"PMC_34805417","title":"NFIB-Mediated lncRNA PVT1 Aggravates Laryngeal Squamous Cell Carcinoma Progression via the miR-1301-3p/MBNL1 Axis.","date":"2021","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/34805417","citation_count":14,"is_preprint":false},{"pmid":"33275244","id":"PMC_33275244","title":"Inhibition of microRNA-346 inhibits myocardial inflammation and apoptosis after myocardial infarction via targeting NFIB.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33275244","citation_count":14,"is_preprint":false},{"pmid":"32064882","id":"PMC_32064882","title":"RGMB-AS1/miR-22-3p/NFIB axis contributes to the progression of gastric cancer.","date":"2020","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/32064882","citation_count":14,"is_preprint":false},{"pmid":"24661679","id":"PMC_24661679","title":"An overlapping set of genes is regulated by both NFIB and the glucocorticoid receptor during lung maturation.","date":"2014","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/24661679","citation_count":14,"is_preprint":false},{"pmid":"34922631","id":"PMC_34922631","title":"MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting nuclear factor I/B (NFIB).","date":"2021","source":"Acta neuropathologica communications","url":"https://pubmed.ncbi.nlm.nih.gov/34922631","citation_count":13,"is_preprint":false},{"pmid":"25664610","id":"PMC_25664610","title":"HIV-1 induced nuclear factor I-B (NF-IB) expression negatively regulates HIV-1 replication through interaction with the long terminal repeat region.","date":"2015","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/25664610","citation_count":13,"is_preprint":false},{"pmid":"31189999","id":"PMC_31189999","title":"MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia.","date":"2019","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/31189999","citation_count":13,"is_preprint":false},{"pmid":"33346791","id":"PMC_33346791","title":"NFIA and NFIB function as tumour suppressors in high-grade glioma in mice.","date":"2021","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/33346791","citation_count":12,"is_preprint":false},{"pmid":"37963187","id":"PMC_37963187","title":"Small Cell Lung Cancer Plasticity Enables NFIB-Independent Metastasis.","date":"2024","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/37963187","citation_count":11,"is_preprint":false},{"pmid":"26021864","id":"PMC_26021864","title":"PAX6 does not regulate Nfia and Nfib expression during neocortical development.","date":"2015","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/26021864","citation_count":11,"is_preprint":false},{"pmid":"33981484","id":"PMC_33981484","title":"NFIB promotes the migration and progression of kidney renal clear cell carcinoma by regulating PINK1 transcription.","date":"2021","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/33981484","citation_count":11,"is_preprint":false},{"pmid":"37950757","id":"PMC_37950757","title":"MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosis.","date":"2023","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/37950757","citation_count":11,"is_preprint":false},{"pmid":"35380509","id":"PMC_35380509","title":"Circ_0007841 knockdown confers cisplatin sensitivity to ovarian cancer cells by down-regulation of NFIB expression in a miR-532-5p-dependent manner.","date":"2022","source":"Journal of chemotherapy (Florence, Italy)","url":"https://pubmed.ncbi.nlm.nih.gov/35380509","citation_count":11,"is_preprint":false},{"pmid":"37604829","id":"PMC_37604829","title":"NFIB facilitates replication licensing by acting as a genome organizer.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37604829","citation_count":11,"is_preprint":false},{"pmid":"36219357","id":"PMC_36219357","title":"Circ_0082182 upregulates the NFIB level via sponging miR-326 to promote oxaliplatin resistance and malignant progression of colorectal cancer cells.","date":"2022","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36219357","citation_count":11,"is_preprint":false},{"pmid":"33829443","id":"PMC_33829443","title":"LncRNA PCAT1 enhances cell proliferation, migration and invasion by miR-508-3p/NFIB axis in diffuse large B-cell lymphoma.","date":"2021","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33829443","citation_count":11,"is_preprint":false},{"pmid":"27213588","id":"PMC_27213588","title":"The impact of the MYB-NFIB fusion proto-oncogene in vivo.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27213588","citation_count":10,"is_preprint":false},{"pmid":"37491379","id":"PMC_37491379","title":"Downregulation of miR-182-5p by NFIB promotes NAD+ salvage synthesis in colorectal cancer by targeting NAMPT.","date":"2023","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/37491379","citation_count":10,"is_preprint":false},{"pmid":"33038688","id":"PMC_33038688","title":"NFIB functions as an oncogene in estrogen receptor-positive breast cancer and is regulated by miR-205-5p.","date":"2020","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/33038688","citation_count":9,"is_preprint":false},{"pmid":"31301736","id":"PMC_31301736","title":"MYB-NFIB gene fusions identified in archival adenoid cystic carcinoma tissue employing NanoString analysis: an exploratory study.","date":"2019","source":"Diagnostic pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31301736","citation_count":9,"is_preprint":false},{"pmid":"35001739","id":"PMC_35001739","title":"Circ_0003645 serves as miR-335-5p sponge to promote the biological process of diffuse large B-cell lymphoma by upregulating NFIB.","date":"2022","source":"Autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/35001739","citation_count":9,"is_preprint":false},{"pmid":"35711020","id":"PMC_35711020","title":"Exosomal miR-626 promotes the malignant behavior of oral cancer cells by targeting NFIB.","date":"2022","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/35711020","citation_count":8,"is_preprint":false},{"pmid":"28830981","id":"PMC_28830981","title":"Nfib hemizygous mice are protected from hyperoxic lung injury and death.","date":"2017","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/28830981","citation_count":8,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51768,"output_tokens":8860,"usd":0.144102},"stage2":{"model":"claude-opus-4-6","input_tokens":12721,"output_tokens":4312,"usd":0.257107},"total_usd":0.401209,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2005,\n      \"finding\": \"Nfib-deficient mice exhibit defects in lung maturation (failure of saccularization, reduced epithelial differentiation markers), callosal agenesis, forebrain defects more severe than Nfia-null, basilar pons formation defects, and hippocampal developmental abnormalities, establishing NFIB as essential for late fetal lung maturation and brain development; heterozygotes also show haploinsufficiency phenotypes.\",\n      \"method\": \"Knockout mouse model with histological, molecular, and anatomical phenotypic analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple defined cellular phenotypes, replicated by independent lab (PMID:11850179)\",\n      \"pmids\": [\"15632069\", \"11850179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Nfib null mutants die early postnatally with severe lung hypoplasia; TGF-β1 and Shh are not downregulated in mutant lung epithelium at late morphogenesis stages, suggesting NFIB-dependent repression of these signaling molecules is required for normal lung maturation.\",\n      \"method\": \"Knockout mouse model, immunostaining, in situ hybridization\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific molecular pathway implication; independently corroborated\",\n      \"pmids\": [\"11850179\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"NFI-B3, a truncated isoform of NFIB generated by alternative RNA processing (retention of first intron + intron-internal polyadenylation), lacks DNA-binding activity alone but forms heterodimers with other NFI-B, -C, and -X isoforms, reducing their DNA-binding and transcriptional activation in a dominant-negative manner.\",\n      \"method\": \"In vitro transcription assay in NFI-null SL-2 cells, gel shift (EMSA), co-expression of isoforms\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — functional reconstitution in NFI-null cells, EMSA, mechanistic mutagenesis context\",\n      \"pmids\": [\"9099724\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In Nfib-deficient mice, callosal agenesis results from non-cell-autonomous defects: (1) midline radial progenitors fail to differentiate into mature glia (not due to proliferation/apoptosis changes), and (2) cingulate cortex neurons that express Nfib fail to extend neuropilin-1-positive pioneering axons across the midline, with diminished neuropilin-1 expression.\",\n      \"method\": \"Knockout mouse histology, retrograde tracer labeling, immunohistochemistry, cellular proliferation/apoptosis assays\",\n      \"journal\": \"Neural development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing two distinct non-cell-autonomous mechanisms in KO\",\n      \"pmids\": [\"19961580\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In Nfib-null mice, development of the basilar pontine nuclei is delayed (neurons migrate 1–2 days later than controls) and fewer pontine neurons are produced; other mossy fiber nuclei of the caudal medulla also show developmental delay. Nfia and Nfix null mice show no pontine phenotype, indicating Nfib-specific action.\",\n      \"method\": \"Knockout mouse immunohistochemistry, comparative analysis of Nfia and Nfix null mice\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific neuronal phenotype and genetic specificity established by paralog comparison\",\n      \"pmids\": [\"19107796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Hair-follicle-stem-cell-specific conditional knockout of Nfib in mice uncouples melanocyte stem cell synchrony from the hair cycle: loss of NFIB in hair follicle stem cells promotes premature melanocyte stem cell proliferation and differentiation via ectopic activation of the NFIB target Edn2 (endothelin 2). Endothelin receptor antagonists or KIT-blocking antibodies rescue the premature melanocyte differentiation phenotype.\",\n      \"method\": \"Conditional KO mouse, ChIP-seq, transcriptional profiling, pharmacological rescue with receptor antagonists/antibodies\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — conditional KO, ChIP-seq identification of Edn2 as direct target, multiple orthogonal rescue experiments\",\n      \"pmids\": [\"23389444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NFIB binds the Ezh2 promoter and represses Ezh2 transcription, thereby limiting neural progenitor cell self-renewal during cortical development; Nfib-null mice show increased EZH2 expression and excess proliferating ventricular zone progenitors, with misregulation of downstream EZH2 epigenetic targets.\",\n      \"method\": \"Knockout mouse, ChIP (NFIB binding to Ezh2 promoter), NFIB overexpression reporter assay, immunohistochemistry\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct promoter binding (ChIP), overexpression repression assay, and KO phenotype with multiple orthogonal methods\",\n      \"pmids\": [\"24553933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In a mouse SCLC model, Nfib copy-number amplification correlates with widespread opening of distal chromatin regulatory elements genome-wide; Nfib is necessary and sufficient to increase chromatin accessibility at intergenic regions and drives pro-metastatic neuronal gene expression programs, promoting metastatic spread of SCLC.\",\n      \"method\": \"Genetically engineered mouse model (GEMM), ATAC-seq (chromatin accessibility), NFIB KD/OE in cancer cells, in vivo metastasis assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genome-wide chromatin profiling, functional KD/OE with in vivo metastasis readout, multiple orthogonal methods\",\n      \"pmids\": [\"27374332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NFIB overexpression specifically promotes metastatic spread (not just primary tumor growth) in Rb1/Trp53-deleted mouse SCLC models; high NFIB levels are associated with poorly differentiated, E-cadherin-negative invasive tumor cell populations.\",\n      \"method\": \"Mouse SCLC model with NFIB overexpression, histological and immunophenotypic analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo GEMM with defined metastatic phenotype; corroborated by independent SCLC study (PMID:27374332)\",\n      \"pmids\": [\"27373156\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In mouse SCLC models, Nfib overexpression cooperates with Rb1/Trp53 deletion to accelerate SCLC; Nfib suppression in cell lines increases apoptosis and reduces proliferation; Nfib transcriptionally regulates axon guidance, focal adhesion, and extracellular matrix-receptor interaction gene networks; Nfib amplifications are more frequent in liver metastases than primary tumors.\",\n      \"method\": \"Mouse SCLC model (doxycycline-inducible Nfib overexpression), cell line Nfib knockdown, transcriptional profiling\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo mouse model plus transcriptome analysis, multiple orthogonal approaches\",\n      \"pmids\": [\"27613844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Drosha directly targets NFIB mRNA to repress its expression in adult hippocampal neural stem cells, independently of Dicer and microRNAs; Drosha deletion activates oligodendrogenesis and reduces neurogenesis, phenotypes that are rescued by NFIB knockdown, establishing a Drosha/NFIB axis that restricts oligodendrocyte fate acquisition.\",\n      \"method\": \"Conditional Drosha KO in adult dentate gyrus NSCs, NFIB knockdown rescue experiments, lineage tracing\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis by double KO/KD rescue, clean cellular phenotype with defined molecular mechanism\",\n      \"pmids\": [\"27545503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NFIB (together with STAT5) co-regulates mammary-specific genetic programs: ChIP-seq demonstrates STAT5 and NFIB bind composite regulatory elements with H3K4me2 enhancer marks and progesterone receptor binding; combined absence of NFIB and STAT5 prevents functional alveoli formation, whereas NFIB alone is not required for alveolar expansion.\",\n      \"method\": \"Mammary-specific conditional Nfib KO, ChIP-seq (NFIB and STAT5), gene expression analysis\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP-seq establishing co-occupancy at enhancers, conditional double KO with defined mammary phenotype\",\n      \"pmids\": [\"24678731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NFIB acts downstream of BRN2 in melanoma to promote migration and invasion via upregulation of the polycomb protein EZH2; NFIB-driven EZH2 upregulation leads to decreased MITF expression, shifting cells to a less proliferative, more invasive phenotype.\",\n      \"method\": \"Knockdown/overexpression in melanoma cells, migration/invasion assays, western blot, gene expression analysis\",\n      \"journal\": \"EBioMedicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — functional KD/OE with defined pathway placement (BRN2→NFIB→EZH2→MITF), single lab\",\n      \"pmids\": [\"28119061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NFIB directly interacts with the CDKN1A (p21) promoter in TP53-mutated TNBC cells to suppress p21 transcription; NFIB knockdown induces p21 upregulation, cell death, and cell cycle arrest, and double knockdown of p21 and NFIB reverses docetaxel-induced growth inhibition, establishing p21 as a key mediator of NFIB's pro-survival, drug-resistance function.\",\n      \"method\": \"ChIP (NFIB binding to CDKN1A promoter), siRNA knockdown, double knockdown rescue experiment, drug sensitivity assays\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct ChIP evidence of promoter occupancy plus genetic epistasis via double knockdown rescue\",\n      \"pmids\": [\"30350349\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In androgen-dependent LNCaP prostate cancer cells, 64.3% of NFIB ChIP-seq binding sites overlap with AR and FOXA1 binding sites; NFIB knockdown increases AR expression and superinduces a subset of AR target genes; loss of Nfib in mouse prostate (renal capsule engraftment model) results in prostatic hyperplasia not resolved by castration, suggesting NFIB is a coregulator of AR action.\",\n      \"method\": \"ChIP-seq (NFIB in LNCaP cells), siRNA knockdown, Nfib KO prostatic renal capsule engraftment\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genome-wide ChIP-seq, functional KD, in vivo engraftment model with defined phenotype\",\n      \"pmids\": [\"26677878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NFIB directly upregulates ERO1A transcription, which enhances HIF1α-VEGFA-mediated angiogenesis to promote metastatic colonization; NFIB overexpression alone (via piggyBac transposon screen) is sufficient to enhance primary mammary tumor growth and lung metastatic colonization.\",\n      \"method\": \"PiggyBac transposon mutagenesis screen, NFIB overexpression in mammary tumor cells, in vivo metastasis assays, mechanistic follow-up on ERO1A-HIF1α-VEGFA pathway\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — in vivo gain-of-function with defined downstream pathway, single lab\",\n      \"pmids\": [\"33751828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NFIB transcriptionally activates Nfix expression in spinal cord; in the absence of Nfia or Nfib, spinal cord NFIX expression is markedly reduced, and NFIB can activate the Nfix promoter in vitro, demonstrating a hierarchical auto-regulatory transcriptional program within the NFI family during spinal cord gliogenesis.\",\n      \"method\": \"Nfia/Nfib knockout mouse spinal cord analysis, in vitro promoter reporter assay\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — KO phenotype plus in vitro promoter assay, single lab\",\n      \"pmids\": [\"29106906\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Combined allelic loss of Nfia and Nfib in mouse cerebral cortex reveals additive/cooperative function: NFIA and NFIB are co-expressed and form heterodimers in vivo (co-immunoprecipitation). Double homozygous KO produces more severe phenotype (increased ventricular enlargement, decreased differentiated glia and neurons) than single KO.\",\n      \"method\": \"Compound Nfia/Nfib knockout mice, co-immunoprecipitation, immunofluorescence, gene expression analysis\",\n      \"journal\": \"Brain and neuroscience advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP demonstrating heterodimer formation in vivo, genetic epistasis by compound KO\",\n      \"pmids\": [\"32166136\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NFIB facilitates replication licensing by associating physically with the pre-replication complex (pre-RC) in mammalian cells; NFIB increases chromatin accessibility at replication origins, binds to and opens nucleosomes (single-molecule magnetic tweezers), and promotes nucleosome eviction (TEM); NFIB deficiency alters chromosome contacts/compartments in G1 and S phase and impairs firing of early-replication domain origins.\",\n      \"method\": \"Co-immunoprecipitation (NFIB with pre-RC components), ChIP-seq/ATAC-seq, single-molecule magnetic tweezers (nucleosome binding/opening), transmission electron microscopy, Hi-C (chromosome contacts)\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple biophysical methods (magnetic tweezers, TEM) plus genomic assays establishing direct interaction with pre-RC and chromatin remodeling activity\",\n      \"pmids\": [\"37604829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CARM1 methylates NFIB, and methylated NFIB recruits TRIM29 as an effector molecule; CARM1 functions as a coactivator for NFIB-dependent transcription. In a mouse SCLC model, the CARM1 methylation site on NFIB and CARM1 itself are both critical for rapid SCLC onset; CARM1 and methylated NFIB maintain similar open chromatin states in tumors.\",\n      \"method\": \"Biochemical substrate identification, co-IP (NFIB-CARM1, NFIB-TRIM29), mouse SCLC model with methylation-site mutant NFIB, ATAC-seq\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical identification of methylation, effector pulldown, in vivo mouse model with point mutant, chromatin profiling\",\n      \"pmids\": [\"36690626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NFIB regulates hepatic CYP2D6 expression: NFIB inhibits CYP2D6 gene expression in Huh7 cells and 3D liver spheroids; carriers of NFIB rs28379954 T>C polymorphism have reduced NFIB expression and elevated risperidone hydroxylation rates (equivalent to CYP2D6 ultrarapid metabolizers), demonstrating NFIB as a transcriptional regulator of CYP2D6 in vivo.\",\n      \"method\": \"3D liver spheroid and Huh7 cell overexpression/inhibition, in vivo pharmacokinetic analysis in 604 patients genotyped for NFIB and CYP2D6\",\n      \"journal\": \"Clinical pharmacology and therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro functional assay plus large in vivo patient cohort validating regulatory mechanism\",\n      \"pmids\": [\"35253216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NFIB directly binds the NDUFA4L2 promoter region and promotes its transcription; NFIB-upregulated NDUFA4L2 inhibits sorafenib-induced reactive oxygen species accumulation, conferring sorafenib resistance in hepatocellular carcinoma cells.\",\n      \"method\": \"ChIP (NFIB binding to NDUFA4L2 promoter), NFIB knockdown in HCC cells, ROS measurement, drug sensitivity assays\",\n      \"journal\": \"Cancer science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP establishing direct promoter occupancy, functional KD with defined ROS/drug resistance phenotype, single lab\",\n      \"pmids\": [\"36369883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"NFIB directly binds promoters of CDH1 (E-cadherin) and VIM (vimentin) to regulate EMT-related transcription independently of canonical EMT transcription factors; NFIB protein stability in AR-negative CRPC is regulated by m6A: YTHDF2 recognizes m6A-methylated NFIB mRNA to increase its stability, while downregulation of TRIM8 (its E3 ubiquitin ligase, itself translationally reduced by m6A modification via ALKBH5 reduction) increases NFIB protein stability.\",\n      \"method\": \"ChIP (NFIB at CDH1 and VIM promoters), NFIB loss-of-function, m6A-RIP/MeRIP, YTHDF2 and TRIM8 functional studies, in vivo metastasis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP identifying direct gene targets, m6A sequencing, ubiquitin ligase identification, multiple orthogonal mechanisms in one study\",\n      \"pmids\": [\"38536119\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NFIB directly binds the PINK1 promoter and transcriptionally regulates PINK1 expression in kidney renal clear cell carcinoma, promoting tumor progression and metastasis.\",\n      \"method\": \"ChIP (NFIB at PINK1 promoter), NFIB knockdown, in vitro migration/invasion assays\",\n      \"journal\": \"PeerJ\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — ChIP demonstrating direct promoter binding, functional KD, single lab\",\n      \"pmids\": [\"33981484\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NFIB binds the ITGA6 promoter (chromatin immunoprecipitation) in colorectal cancer cells and activates ITGA6 transcription to promote cell metastasis; miR-302a directly targets the NFIB 3'-UTR (luciferase reporter assay) to suppress this pro-metastatic NFIB→ITGA6 axis.\",\n      \"method\": \"ChIP (NFIB at ITGA6 promoter), luciferase 3'-UTR reporter assay, functional migration/invasion assays\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP establishing direct NFIB-ITGA6 promoter binding, functional assays; single lab\",\n      \"pmids\": [\"31754405\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NFIB promotes NFIB-ITGA6-driven metastasis as a direct transcriptional activator of ITGA6; separately, circHIF1A modulates NFIB expression and nuclear translocation through posttranscriptional and posttranslational mechanisms, leading to AKT/STAT3 pathway activation and p21 inhibition in TNBC; NFIB in turn transcriptionally regulates FUS, forming a circHIF1A/NFIB/FUS positive feedback loop.\",\n      \"method\": \"Gain/loss-of-function in TNBC cells and xenografts, posttranslational modification analysis, RNA-protein interaction studies\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple functional experiments but mechanistic detail of posttranslational modification of NFIB not fully resolved, single lab\",\n      \"pmids\": [\"33714984\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NFIB interacts physically with the estrogen receptor ESR1-FOXA1 complex (co-immunoprecipitation) and inhibits ESR1 transactivational potential; FGFR2 signaling augments these interactions to further repress ESR1 target gene expression.\",\n      \"method\": \"Co-immunoprecipitation, gene expression reporter assays, FGFR2 signaling inhibition\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP establishing physical interaction with ESR1-FOXA1 complex, functional transcriptional assay, single lab\",\n      \"pmids\": [\"29180470\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"KDM4D histone demethylase physically interacts with NFIB and MLL1 complex; KDM4D-mediated demethylation of H3K9me3 is required for NFIB and MLL1 complex to deposit H3K4me3 and activate PPARγ and C/EBPα expression during adipogenesis, placing NFIB in a defined chromatin-remodeling hierarchy for adipogenic differentiation.\",\n      \"method\": \"Co-IP (KDM4D-NFIB-MLL1), ChIP (NFIB and MLL1 at target promoters), KDM4D KD/rescue in C3H10T1/2 cells\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP and ChIP establishing physical and functional interaction in chromatin context, single lab\",\n      \"pmids\": [\"32080306\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"HIV-1 infection induces NF-IB (NFIB) expression, and NFIB associates with the HIV-1 long terminal repeat (LTR) region (−386 to −453 nt) as shown by ChIP assay; this association negatively correlates with HIV-1 transcription. NFIB knockdown increases HIV-1 replication in latently infected cells, indicating a repressive role of NFIB at the LTR.\",\n      \"method\": \"ChIP assay (NFIB at HIV-1 LTR), siRNA knockdown of NFIB in J1.1 and J-Lat cells, viral replication measurement\",\n      \"journal\": \"Viruses\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP establishing direct LTR binding, functional KD with viral replication readout, single lab\",\n      \"pmids\": [\"25664610\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NFIB overexpression in hPSC-derived neural precursor cells induces differentiation into functional astrocytes within 2 weeks, recapitulating in vivo astrogliogenesis transcriptomically and physiologically; the MAPK pathway is necessary for NFIB-driven astrocyte differentiation.\",\n      \"method\": \"NFIB overexpression in hPSC-derived NPCs, RNA-seq, functional astrocyte assays, MAPK pathway inhibition\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — defined differentiation phenotype with transcriptomic validation and pathway identification, single lab\",\n      \"pmids\": [\"33949692\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Using conditional gene knockout in SCLC GEMMs, NFIB upregulation contributes to tumor progression but is not strictly required for metastasis; FOXA1/2 pioneer transcription factors were identified as candidate drivers of metastasis in NFIB-knockout SCLC tumors, revealing SCLC plasticity and NFIB-independent metastatic mechanisms.\",\n      \"method\": \"Conditional Nfib knockout in SCLC GEMMs, molecular profiling of NFIB WT vs. KO tumors, identification of FOXA1/2 as compensatory factors\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO in relevant in vivo GEMM, molecular identification of compensatory pathway\",\n      \"pmids\": [\"37963187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NFIB ChIP-seq in mouse lung at E16.5 shows NFIB binds the NFI consensus motif in vivo; this motif is over-represented in promoters of genes under-expressed in Nfib-KO lung at E18.5, indicating NFIB acts as a transcriptional activator of lung maturation genes; 52 genes are co-regulated by NFIB and the glucocorticoid receptor (Nr3c1), overlapping 13.1-fold above chance.\",\n      \"method\": \"ChIP-seq (NFIB in lung E16.5), microarray (Nfib-KO and Nr3c1-KO), motif analysis\",\n      \"journal\": \"BMC genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ChIP-seq with KO transcriptome integration, single lab\",\n      \"pmids\": [\"24661679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"NFIB is identified as a recurrent translocation partner gene of HMGIC (HMGA2) in pleomorphic adenomas of the salivary glands; 3'-RACE and RT-PCR analyses reveal chimeric transcripts where the last five amino acids of NFIB replace the carboxy-terminal segment of HMGIC, established in two independent adenoma cases.\",\n      \"method\": \"3'-RACE analysis, RT-PCR, nucleotide sequencing of fusion transcripts\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct molecular characterization of fusion transcript in two independent tumors; foundational gene fusion discovery\",\n      \"pmids\": [\"9484777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The t(6;9)(q22-23;p23-24) translocation in adenoid cystic carcinoma creates MYB-NFIB fusion transcripts predominantly consisting of MYB exon 14 linked to the last coding exon(s) of NFIB; the minimal deleted region includes MYB exon 15/3'-UTR containing conserved miR-15a/16 and miR-150 target sites, suggesting loss of miRNA-mediated repression of MYB leads to MYB-NFIB overexpression and activation of MYB target genes.\",\n      \"method\": \"RT-PCR, nucleotide sequencing, forced miRNA overexpression in primary ACC cells, molecular characterization of translocation breakpoints\",\n      \"journal\": \"Proceedings of the National Academy of Sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — original molecular characterization of MYB-NFIB fusion with mechanistic miRNA experiment, foundational study with 624 citations\",\n      \"pmids\": [\"19841262\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In pleomorphic adenomas, NFIB fusions with PLAG1 (NFIB-PLAG1) and HMGA2 result in activation of PLAG1 and HMGA2 through promoter swapping; analysis of the NFIB chromatin landscape reveals super-enhancers in the 5'- and 3'-parts of the NFIB locus, suggesting PLAG1 and HMGA2 are activated by enhancer-hijacking events in which NFIB super-enhancers are translocated upstream of these oncogenes.\",\n      \"method\": \"RNA-seq, RT-PCR (fusion transcript identification), chromatin landscape analysis (super-enhancer identification)\",\n      \"journal\": \"Genes, chromosomes & cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct fusion transcript identification plus chromatin landscape analysis; enhancer-hijacking mechanism is inferential without direct functional test\",\n      \"pmids\": [\"32654217\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NFIB downregulates miR-182-5p, which directly targets NAMPT (the rate-limiting enzyme of NAD+ salvage synthesis); this NFIB→miR-182-5p→NAMPT axis promotes NAD+ production and colorectal cancer cell proliferation; NAD+ precursor NMN supplementation rescues proliferation in NFIB-knockdown cells.\",\n      \"method\": \"NFIB KD/OE in CRC cells, miRNA profiling, luciferase 3'-UTR reporter (miR-182-5p→NAMPT), NAD+ measurement, NMN rescue\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — functional pathway defined with metabolic rescue, single lab\",\n      \"pmids\": [\"37491379\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NFIB is a multifunctional nuclear factor I family transcription factor that binds the NFI consensus motif to directly activate or repress target gene promoters (including Ezh2, CDKN1A/p21, NDUFA4L2, PINK1, ITGA6, NAMPT, CYP2D6, and Edn2), forms homodimers and heterodimers (including with NFIA) as well as complexes with STAT5, CARM1, AR/FOXA1, ESR1-FOXA1, and the pre-replication complex, undergoes CARM1-mediated arginine methylation that recruits TRIM29 to coactivate transcription and is regulated by YTHDF2-dependent m6A mRNA stabilization and TRIM8-mediated ubiquitination; it increases chromatin accessibility genome-wide by binding and opening nucleosomes to facilitate replication origin firing and to drive metastatic gene expression programs, and is essential in vivo for lung maturation, corpus callosum formation, hippocampal and pontine development, and astrocytic differentiation, while being hijacked as an oncogenic fusion partner (MYB-NFIB, HMGA2-NFIB, PLAG1-NFIB, MYBL1-NFIB) in multiple cancer types.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NFIB is a nuclear factor I (NFI) family transcription factor that binds the NFI consensus motif as homodimers or heterodimers (with NFIA) to activate or repress diverse target gene promoters, thereby orchestrating lung maturation, brain development, gliogenesis, and chromatin accessibility programs [PMID:15632069, PMID:9099724, PMID:32166136]. NFIB directly binds and opens nucleosomes to increase chromatin accessibility at replication origins and distal regulatory elements, facilitating replication licensing through association with the pre-replication complex and driving metastatic gene expression programs in small cell lung cancer [PMID:37604829, PMID:27374332]. It directly regulates transcription of targets including Ezh2, CDKN1A/p21, Edn2, NDUFA4L2, ITGA6, PINK1, CYP2D6, and NFIX, and is itself regulated post-transcriptionally by Drosha-mediated mRNA cleavage, YTHDF2-dependent m6A stabilization, and TRIM8-mediated ubiquitination, while serving as a CARM1 methylation substrate that recruits TRIM29 for transcriptional coactivation [PMID:24553933, PMID:13889444, PMID:30350349, PMID:27545503, PMID:38536119, PMID:36690626]. NFIB is recurrently hijacked as a fusion partner (MYB-NFIB, HMGA2-NFIB, PLAG1-NFIB) in adenoid cystic carcinoma and pleomorphic adenoma, where its super-enhancers drive oncogene activation through enhancer hijacking [PMID:19841262, PMID:9484777, PMID:32654217].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"The discovery that a truncated NFIB isoform (NFI-B3) acts as a dominant-negative by heterodimerizing with full-length NFI proteins established that NFIB functions through dimerization-dependent DNA binding and that alternative splicing generates regulatory diversity within the NFI family.\",\n      \"evidence\": \"Reconstitution in NFI-null Drosophila SL-2 cells with EMSA and transcription assays\",\n      \"pmids\": [\"9099724\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crystal structure of NFIB homodimer/heterodimer not determined\", \"In vivo relevance of NFI-B3 dominant-negative isoform not tested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Identification of HMGA2-NFIB fusion transcripts in pleomorphic adenomas revealed that the NFIB locus is a recurrent translocation target in salivary gland tumors, later extended to MYB-NFIB in adenoid cystic carcinoma and PLAG1-NFIB fusions.\",\n      \"evidence\": \"3'-RACE and RT-PCR in two independent pleomorphic adenoma cases; MYB-NFIB fusion characterized by RT-PCR and sequencing in ACC\",\n      \"pmids\": [\"9484777\", \"19841262\", \"32654217\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct functional consequence of NFIB sequences in chimeric proteins not fully resolved\", \"Enhancer-hijacking mechanism for NFIB super-enhancers inferred but not functionally validated by deletion\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Nfib knockout mice dying perinatally with severe lung hypoplasia and failure to downregulate TGF-β1/Shh established NFIB as essential for late fetal lung maturation, answering whether any single NFI family member is non-redundant in organogenesis.\",\n      \"evidence\": \"Nfib-null mouse with histology, immunostaining, and in situ hybridization\",\n      \"pmids\": [\"11850179\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets mediating lung saccularization were not identified in this study\", \"Whether NFIB represses TGF-β1/Shh directly or indirectly was unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Expanded phenotyping of Nfib-null mice revealed callosal agenesis, hippocampal defects, and basilar pons malformation — more severe than Nfia loss — establishing NFIB as the predominant NFI member in forebrain and hindbrain development.\",\n      \"evidence\": \"Nfib knockout with histological and anatomical analysis; Nfib-specific pontine phenotype confirmed by comparison with Nfia/Nfix nulls\",\n      \"pmids\": [\"15632069\", \"19107796\", \"19961580\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-autonomous vs. non-cell-autonomous contributions initially unclear (partially resolved for corpus callosum by PMID:19961580)\", \"Downstream transcriptional targets in brain not yet identified\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Conditional Nfib knockout in hair follicle stem cells, combined with ChIP-seq, identified Edn2 as a direct NFIB target whose ectopic activation drives premature melanocyte stem cell differentiation — the first demonstration that NFIB coordinates inter-lineage stem cell niche signaling.\",\n      \"evidence\": \"Conditional KO mouse, ChIP-seq, pharmacological rescue with endothelin receptor antagonists and KIT-blocking antibodies\",\n      \"pmids\": [\"23389444\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NFIB directly represses or indirectly controls Edn2 chromatin state not fully dissected\", \"Relevance to human hair graying not demonstrated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"ChIP and reporter assays showed NFIB directly binds and represses the Ezh2 promoter, limiting neural progenitor self-renewal; genome-wide ChIP-seq in fetal lung confirmed NFIB recognizes the NFI consensus motif in vivo and co-regulates genes with the glucocorticoid receptor, defining NFIB's dual role as a direct activator and repressor.\",\n      \"evidence\": \"ChIP/ChIP-seq in brain and lung, Nfib-KO microarray, overexpression reporter assays\",\n      \"pmids\": [\"24553933\", \"24661679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide activator vs. repressor target classification incomplete\", \"Mechanism of context-dependent switching between activation and repression unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"ChIP-seq in mammary epithelium revealed NFIB co-occupies enhancers with STAT5, and combined Nfib/Stat5 loss prevents alveolar function, establishing NFIB as a tissue-specific cofactor that collaborates with lineage-determining transcription factors at enhancers.\",\n      \"evidence\": \"Mammary conditional Nfib KO, ChIP-seq for NFIB and STAT5, gene expression analysis\",\n      \"pmids\": [\"24678731\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NFIB directly interacts with STAT5 protein was not shown by co-IP in this study\", \"Mechanism of enhancer selection by NFIB-STAT5 unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"ChIP-seq in prostate cancer cells demonstrated extensive NFIB co-binding with AR and FOXA1 at regulatory elements, and Nfib loss caused castration-resistant prostatic hyperplasia, revealing NFIB as a coregulator that restrains androgen receptor signaling.\",\n      \"evidence\": \"ChIP-seq in LNCaP cells, siRNA knockdown, Nfib-KO prostatic engraftment in vivo\",\n      \"pmids\": [\"26677878\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct physical interaction between NFIB and AR not shown by co-IP\", \"Mechanism by which NFIB restrains AR target gene expression unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Three independent studies in SCLC mouse models converged to show that NFIB amplification/overexpression drives metastasis by opening distal chromatin at thousands of regulatory elements genome-wide, establishing NFIB as a chromatin accessibility factor — not merely a classical transcription factor — that enables metastatic gene programs.\",\n      \"evidence\": \"ATAC-seq, NFIB KD/OE, in vivo metastasis assays in Rb1/Trp53-deleted GEMMs\",\n      \"pmids\": [\"27374332\", \"27373156\", \"27613844\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biophysical mechanism of chromatin opening not yet determined (resolved later in 2020)\", \"Whether NFIB is strictly required for metastasis or can be compensated was unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Discovery that Drosha directly destabilizes NFIB mRNA independently of Dicer/miRNAs to restrict oligodendrocyte fate in adult hippocampal stem cells established a non-canonical post-transcriptional control layer for NFIB levels during cell fate decisions.\",\n      \"evidence\": \"Conditional Drosha KO in adult NSCs, NFIB knockdown rescue, lineage tracing\",\n      \"pmids\": [\"27545503\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Drosha cleavage site on NFIB mRNA not mapped\", \"Whether this mechanism operates outside hippocampus unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Multiple studies expanded NFIB's transcriptional network: NFIB activates NFIX in spinal cord gliogenesis (establishing NFI family hierarchy), forms heterodimers with NFIA in vivo (co-IP), interacts with ESR1-FOXA1 to repress estrogen receptor signaling, and in melanoma acts downstream of BRN2 to upregulate EZH2.\",\n      \"evidence\": \"Compound Nfia/Nfib KO, co-IP, promoter reporter assays, KD/OE in melanoma and breast cancer cells\",\n      \"pmids\": [\"29106906\", \"32166136\", \"29180470\", \"28119061\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Heterodimer stoichiometry and DNA-binding preference differences between NFIB homodimers and NFIA-NFIB heterodimers not characterized\", \"NFIB context-dependent switch from Ezh2 repressor (brain) to EZH2 activator (melanoma) mechanistically unexplained\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"ChIP demonstrated NFIB directly occupies the CDKN1A (p21) promoter in TP53-mutant TNBC; double knockdown of p21 and NFIB rescued docetaxel sensitivity, establishing p21 as a critical downstream effector of NFIB-mediated drug resistance.\",\n      \"evidence\": \"ChIP, siRNA single and double knockdown, drug sensitivity assays in TNBC cells\",\n      \"pmids\": [\"30350349\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NFIB repression of p21 requires TP53 mutation context not tested in TP53-WT cells\", \"Generalizability to other chemotherapeutic agents not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Single-molecule magnetic tweezers and TEM revealed NFIB directly binds and opens nucleosomes, and co-IP showed it associates with pre-replication complex components; NFIB deficiency altered replication origin firing and 3D chromosome compartments, unifying NFIB's chromatin remodeling and replication licensing activities.\",\n      \"evidence\": \"Magnetic tweezers, TEM, co-IP with pre-RC, ChIP-seq/ATAC-seq, Hi-C in mammalian cells\",\n      \"pmids\": [\"37604829\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether nucleosome opening is catalytic or stoichiometric not determined\", \"Structural basis of NFIB-nucleosome interaction unknown\", \"Relative contribution of replication vs. transcription functions to metastasis not separated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of CARM1 as a methyltransferase for NFIB, with methylated NFIB recruiting TRIM29, established the first defined post-translational modification-effector axis for NFIB; in vivo, a methylation-site mutant delayed SCLC onset as severely as CARM1 loss.\",\n      \"evidence\": \"Biochemical substrate identification, co-IP, ATAC-seq, mouse SCLC model with NFIB methylation-site point mutant\",\n      \"pmids\": [\"36690626\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"TRIM29's effector mechanism at NFIB target sites not defined\", \"Whether CARM1-NFIB axis operates outside SCLC unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery that YTHDF2 stabilizes m6A-modified NFIB mRNA while TRIM8 ubiquitinates NFIB protein for degradation provided dual epitranscriptomic/proteasomal control of NFIB levels, and conditional Nfib KO in SCLC GEMMs revealed FOXA1/2 can compensate for NFIB loss in driving metastasis.\",\n      \"evidence\": \"m6A-RIP, YTHDF2/TRIM8 functional studies, conditional Nfib KO in SCLC GEMM with molecular profiling\",\n      \"pmids\": [\"38536119\", \"37963187\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether YTHDF2-NFIB and TRIM8-NFIB axes interact or are independent pathways not tested\", \"FOXA1/2 compensation mechanism and whether it requires chromatin opening activity unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of NFIB's nucleosome-opening activity, how the same factor switches between transcriptional activation and repression in different tissues, and whether NFIB's replication licensing and transcriptional functions are mechanistically separable.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure of NFIB bound to nucleosome or DNA\", \"Context-dependent activation vs. repression mechanism unknown\", \"Replication vs. transcription functions not genetically separated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2, 6, 7, 13, 14, 18, 31]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 5, 6, 13, 16, 20, 21, 24, 31]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [6, 7, 14, 18, 31]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 5, 6, 7, 13, 14, 16, 20, 21, 24, 31]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [7, 18, 19]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 3, 4, 5, 6, 10, 29]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7, 8, 9, 33]}\n    ],\n    \"complexes\": [\n      \"NFI homodimer/heterodimer\",\n      \"pre-replication complex (pre-RC)\"\n    ],\n    \"partners\": [\n      \"NFIA\",\n      \"STAT5\",\n      \"CARM1\",\n      \"TRIM29\",\n      \"FOXA1\",\n      \"ESR1\",\n      \"KDM4D\",\n      \"TRIM8\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}